Statement of the AGNP in the Context of the Planned Formation of a Fixed Reference Price Group “GABA-Analogues”, November 21, 2011

• References

• 1 Bandelow B, Zohar J, Hollander E et al. WFSBP Task Force on the treatment guidelines for anxiety, obsessive-compulsive, posttraumatic stress disorders. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders. First revision. World J Biol Psychiatry 2008; 9: 248-312
• 2 Feltner DE, Crockatt JG, Dubovsky SJ et al. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 2003; 23: 240-224
• 3 Feltner D, Wittchen HU, Kavoussi R et al. Long-term efficacy of pregabalin in gener­alized anxiety disorder. Int Clin Psycho­pharmacol 2008; 23: 18-28
• 4 Hildalgo RB, Tupler LA, Davidson JRT. An effect-size analysis of pharmacological treatments for generalized anxiety disorder. J Psychopharmacol 2007; 21: 864-872
• 5 Kasper S, Herman B, Nivoli G et al. Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial. Int Clin Psychopharmacol 2009; 24: 87-96
• 6 Montgomery SA, Tobias K, Zornberg GL et al. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. J Clin Psychiatry 2006; 67: 771-782
• 7 Montgomery S, Chatamra K, Pauer L et al. Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. Br J Psychiatry 2008; 193: 389-394
• 8 Pande AC, Crockatt JG, Feltner DE et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 2003; 160: 533-540
• 9 Pohl RB, Feltner DE, Fieve RR et al. Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing. J Clin Psychopharmacol 2005; 25: 151-158
• 10 Rickels K, Pollack MH, Feltner DE et al. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry 2005; 62: 1022-1030